Hoffman Reid, beneficial owner of Vor Biopharma, sells $1.13 million in VOR stock
NeutralFinancial Markets

Hoffman Reid, the beneficial owner of Vor Biopharma, has sold $1.13 million worth of VOR stock. This transaction is significant as it reflects Reid's financial decisions regarding his investment in the biopharmaceutical company, which could influence market perceptions and investor confidence in Vor Biopharma's future.
— Curated by the World Pulse Now AI Editorial System